August 24, 2016
August 19, 2016
August 18, 2016
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely. UC Berkeley researchers have now found a way to boost the efficiency with which CRISPR-Cas9 cuts and disables genes up to fivefold, in most types of human cells, making it easler to create and study knockout cell lines and, potentially, disable a mutant gene as a form of human therapy.
August 17, 2016
Search-and-rescue dogs are prized for their ability to sniff out a hiker buried in deep snow. But how exactly do their noses work? UC Berkeley neuroscientist Lucia Jacobs is exploring the smell navigation mechanics of tracking dogs as well as smaller animals who use a similar olfactory GPS. Her research was featured on the PBS NewsHour Aug. 16, and is highlighted in the video below.
August 16, 2016
What’s life like aboard a scientific research vessel plying the California coast deploying robots to unlock important data about climate change? A team of scientists and engineers from Lawrence Berkeley National Laboratory and UC Berkeley have just set out on such a venture.
August 15, 2016
August 10, 2016
Josh Prenot, a gold medal contender and Physics student, is featured in The Wall Street Journal.
August 8, 2016
August 5, 2016
Fifty Golden Bears will compete in the 2016 Olympics this month, and nearly half are students who graduated from the College of Letters & Science or are currently declared in an L&S major. Tune into the Olympics broadcast to see these astounding Bears try to bring home gold. For a list of all fifty Golden Bears competing in Rio, see CalBears.
August 4, 2016
UC Berkeley engineers have built the first dust-sized, wireless sensors that can be implanted in the body, bringing closer the day when a Fitbit-like device could monitor internal nerves, muscles or organs in real time.
August 2, 2016
August 1, 2016
The New York Times profiles immunology research and the discovery made by Dr. Jim Allison during his tenure at the UC Berkeley.
July 28, 2016
Most cancer drugs are designed to halt cell growth, the hallmark of cancer, and one popular target is the pathway that controls the production of a cell’s thousands of proteins. UC Berkeley researchers have now found a promising new drug target within that pathway that is appealing, in part, because it appears to control production of only a few percent of the body’s many proteins, those critical to regulating the growth and proliferation of cells.